viTToria biotherapeutics
Keith Westby currently serves as Chief Operating Officer at Vittoria Biotherapeutics, Inc., a position held since January 2024. Prior to this role, Westby was Chief Operating Officer at IVERIC bio from April 2019 to December 2023, where the focus was on developing novel gene therapies for retinal diseases. Westby’s extensive experience also includes leadership positions at Ophthotech Corp, overseeing operations and development from 2007 to 2019, and at Pharmasset, Inc. as Director of Project and Alliance Management. Additionally, Westby held management roles at Eyetech Pharmaceuticals and Tunnell Consulting. Educational qualifications include an MBA from Columbia Business School, a Master of Science in Engineering Management from Drexel University, and a Bachelor of Science in Applied Physics from SUNY Geneseo.
This person is not in any teams
This person is not in any offices
viTToria biotherapeutics
Vittoria Biotherapeutics develops gene-edited cell therapies. they provide next-generation, paradigm-shifting T-cell therapeutics that address unmet medical needs. Senza5 Technology from viTToria improves the efficacy, safety, and utility of cell-based treatments in preclinical settings.